Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma
Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma
Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies
Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma
FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC
Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform
Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer
Improving African representation in breast cancer genomics
Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma
Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation